ZimVie Hosts Inaugural Investor Day; Provides 2022 Financial Outlook

Go back to ZimVie Hosts Inaugural Investor Day; Provides 2022 Financial Outlook

Zimmer Biomet (ZBH) PT Lowered to $128 at Truist Securities

February 8, 2022 6:38 AM EST

Truist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $128.00 (from $145.00) while maintaining a Buy rating following results.

The analyst commented, "We remain Buy rated following a noisy 4Q/'22 guide, which disappointed on a more sanguine COVID... More